- Home
- GNPX vs XPON Comparison
GNPX vs XPON Comparison
Compare GNPX & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNPX
- XPON
- Stock Information
- Founded
- GNPX 2009
- XPON 2016
- Country
- GNPX United States
- XPON United States
- Employees
- GNPX N/A
- XPON N/A
- Industry
- GNPX Biotechnology: Pharmaceutical Preparations
- XPON Electronic Components
- Sector
- GNPX Health Care
- XPON Technology
- Exchange
- GNPX Nasdaq
- XPON Nasdaq
- Market Cap
- GNPX 5.5M
- XPON 6.2M
- IPO Year
- GNPX 2018
- XPON 2022
- Fundamental
- Price
- GNPX $0.31
- XPON $1.37
- Analyst Decision
- GNPX
- XPON
- Analyst Count
- GNPX 0
- XPON 0
- Target Price
- GNPX N/A
- XPON N/A
- AVG Volume (30 Days)
- GNPX 23.7M
- XPON 21.8M
- Earning Date
- GNPX 08-14-2025
- XPON 08-13-2025
- Dividend Yield
- GNPX N/A
- XPON N/A
- EPS Growth
- GNPX N/A
- XPON N/A
- EPS
- GNPX N/A
- XPON N/A
- Revenue
- GNPX N/A
- XPON $8,414,250.00
- Revenue This Year
- GNPX N/A
- XPON $61.26
- Revenue Next Year
- GNPX N/A
- XPON N/A
- P/E Ratio
- GNPX N/A
- XPON N/A
- Revenue Growth
- GNPX N/A
- XPON 68.33
- 52 Week Low
- GNPX $0.14
- XPON $0.60
- 52 Week High
- GNPX $3.97
- XPON $22.81
- Technical
- Relative Strength Index (RSI)
- GNPX 69.58
- XPON 49.42
- Support Level
- GNPX $0.20
- XPON $1.15
- Resistance Level
- GNPX $0.40
- XPON $1.49
- Average True Range (ATR)
- GNPX 0.04
- XPON 0.14
- MACD
- GNPX 0.02
- XPON -0.03
- Stochastic Oscillator
- GNPX 61.56
- XPON 38.93
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.